TENAX THERAPEUTICS, INC. Liabilities Average Amount Outstanding
TENAX THERAPEUTICS, INC. (TENX) reported Liabilities Average Amount Outstanding of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Notes › Financial Services
us-gaap:LiabilitiesAverageAmountOutstanding · last filed 2024-03-28
- TENAX THERAPEUTICS, INC. liabilities average amount outstanding for fiscal 2023 was $0.00.
- TENAX THERAPEUTICS, INC. liabilities average amount outstanding for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- TENAX THERAPEUTICS, INC. liabilities average amount outstanding for fiscal 2021 was $229.75K.
- TENAX THERAPEUTICS, INC. liabilities average amount outstanding for fiscal 2020 was $0.00.
| Period end | Liabilities Average Amount Outstanding 12 month |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
| 2021-12-31 | $229.75K 10-K · filed 2023-03-31 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |